SCHEMBL1053201

SCHEMBL1053201

CCN(C)C(=S)S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27363679 0.97
SCHEMBL27992539 0.97
SCHEMBL27992317 0.97
Selenium SCHEMBL11492106 0.97 ABCB11 (0.52)
SCHEMBL11563028 0.97
Methylethylamine SCHEMBL11524258 0.87 ABCB11 (0.44)
SCHEMBL1286323 0.77
SCHEMBL434749 0.75
SCHEMBL27407070 0.75
SCHEMBL27992311 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115745126-A Heavy metal wastewater treatment method and application 深圳市清源净水器材有限公司 2023-03-07 CN claimed
EP-2625159-B1 PROCESS FOR INHIBITING UNWANTED FREE-RADICAL POLYMERIZATION OF ACRYLIC ACID PRESENT IN A LIQUID PHASE P BASF SE (DE) 2024-10-02 EP disclosed
CN-115745126-A Heavy metal wastewater treatment method and application 深圳市清源净水器材有限公司 2023-03-07 CN disclosed
US-20230059705-A1 NITRIFICATION INHIBITOR FUNGICIDE COMPOSITION AND USE THEREOF VERDESIAN LIFE SCIENCES U.S., LLC 2023-02-23 US disclosed
US-11541027-B2 Use of dianhydrogalactitol and analogs or derivatives thereof in combination with platinum-containing antineoplastic agents to treat non-small-cell carcinoma of the lung and brain metastases DEL MAR PHARMACEUTICALS (BC) LTD. (CA) 2023-01-03 US disclosed
US-11026914-B2 Use of dianhydrogalactitol and analogs and derivatives thereof to treat recurrent malignant glioma or progressive secondary brain tumor DEL MAR PHARMACEUTICALS (BC) LTD. (CA) 2021-06-08 US disclosed
US-10953099-B2 Compositions comprising a metal source, dithiocarbamate and cyclodextrin Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) 2021-03-23 US disclosed
EP-3125920-B1 DIANHYDROGALACTITOL, DIACETYLDIANHYDROGALACTITOL OR DIBROMODULCITOL TO TREAT NON-SMALL-CELL CARCINOMA OF THE LUNG AND OVARIAN CANCER DEL MAR PHARMACEUTICALS (CA) 2020-12-23 EP disclosed
US-20190328886-A1 COMPOSITIONS COMPRISING A METAL SOURCE, DITHIOCARBAMATE AND CYCLODEXTRIN Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) 2019-10-31 US disclosed
US-20190269646-A9 USE OF DIANHYDROGALACTITOL AND ANALOGS OR DERIVATIVES THEREOF IN COMBINATION WITH PLATINUM-CONTAINING ANTINEOPLASTIC AGENTS TO TREAT NON-SMALL-CELL CARCINOMA OF THE LUNG AND BRAIN METASTASES DEL MAR PHARMACEUTICALS (BC) LTD. (CA) 2019-09-05 US disclosed
US-20090240067-A1 METHOD OF PRODUCING A BISBENZODITHIOL COMPOUND FUJIFILM CORPORATION (JP) 2009-09-24 US disclosed
US-20090240067-A1 METHOD OF PRODUCING A BISBENZODITHIOL COMPOUND FUJIFILM CORPORATION (JP) 2009-09-24 US disclosed
WO-2007012630-A1 CONDUCTIVE OR SEMI-CONDUCTIVE MATERIAL MODIFIED BY ELECTROCHEMICAL GRAFTING OF POLYMER FILMS COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2007-02-01 WO disclosed
CN-1085218-C Olefin polymerization catalyst ASAHI CHEMICAL IND (JP) 2002-05-22 CN disclosed
CN-1044248-C Ternary complex of rare-earth (N,N-dialkyl dithio-amino formic acid)--(1,10-ortho-phenanthroline) LANZHOU CHEM PHYS INST (CN) 1999-07-21 CN disclosed
CN-1146456-A Ternary complex of rare-earth (N,N-dialkyl dithio-amino formic acid)--(1,10-ortho-phenanthroline) LANZHOU CHEM PHYS INST (CN) 1997-04-02 CN disclosed
US-5294430-A Side effect reduction of antitumor agents UNIVERSITY OF ROCHESTER (US) 1994-03-15 US disclosed
US-5187193-A Administering dithiocarbamate derivative UNIVERSITY OF ROCHESTER (US) 1993-02-16 US disclosed
US-5169765-A Adding substituted dithiocarbamic acids(or derivatives) to cultures, then isolation of growth regulators, for treatment or prevention of bone marrow damage caused by cancer treatment UNIVERSITY OF ROCHESTER (US) 1992-12-08 US disclosed
WO-1991005571-A1 METHOD FOR PRODUCING BONE MARROW GROWTH CELL FACTORS UNIVERSITY OF ROCHESTER (US) 1991-05-02 WO disclosed